AbCellera Biologics ABCL Earnings Call Transcripts

NASDAQ ABCL
$12.50 +0.62 (+5.22%)
At close: Nov 9, 2026 · 4:00 PM EST
19 earnings calls on file for AbCellera Biologics, from Q1 2021 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

AbCellera Biologics Q2 2026 Earnings Call

Aug 5, 2026 4,539 words · 20 min read
  • Tryn StimartChief Legal and Compliance Officer
  • Carl L. HansenPresident and Chief Executive Officer
  • Andrew BoothChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

AbCellera Biologics Earnings Call Transcripts

Calls19
LatestAug 5, 2026
SinceQ1 2021

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

All 19 AbCellera Biologics transcripts Register to get access to AbCellera Biologics’s earnings call transcripts.